Roles of reactive oxygen and nitrogen species in lung injury

Lung Injury: Mechanisms, Pathophysiology, and Therapy

Volumn , Issue , 2005, Pages 227-268

  Davis, Ian C ^a   Lang, John D ^a   Matalon, Sadis ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862526360     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (217)

1. 2breathing on permeability of alveolar epithelium to solute. J Appl Physiol 1981; 50:859-863.
2. Holm BA, Matalon S. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth Analg 1989; 69: 805-818.
3. Nicod LP. Pulmonary defence mechanisms. Respiration 1999; 66:2-11.
4. Fridovich I. Fundamental aspects of reactive oxygen species, or what’s the matter with oxygen? Ann N Y Acad Sci 1999; 893:13-18.
5. Nauseef WM. The NADPH-dependent oxidase of phagocytes. Proc Assoc Am Phys 1999; 111:373-382.
6. Kobayashi T, Seguchi H. Novel insight into current models of NADPH oxidase regulation, assembly and localization in human polymorphonuclear leukocytes. Histol Histopathol 1999; 14:1295-1308.
7. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992; 298:446-451.
8. Punjabi CJ, Laskin JD, Pendino KJ, Goller NL, Durham SK, Laskin DL. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol 1994; 11:165-172.
9. Barnes PJ. Air pollution and asthma: molecular mechanisms. Mol Med Today 1995; 1:149-155.
10. Martin LD, Krunkosky TM, Dye JA, Fischer BM, Jiang NF, Rochelle LG, Akley NJ, Dreher KL, Adler KB. The role of reactive oxygen and nitrogen species in the response of airway epithelium to particulates. Environ Health Perspect 1997; 105(suppl 5):1301-1307.
11. Imlay JA, Fridovich I. Assay of metabolic superoxide production in Escherichia coli. J Biol Chem 1991; 266:6957-6965.
12. Aust SD, Roerig DL, Pederson TC. Evidence for superoxide generation by NADPH-cytochrome c reductase of rat liver microsomes. Biochem Biophys Res Commun 1972; 47:1133-1137.
13. Boveris A. Mitochondrial generation of superoxide and hydrogen peroxide. Adv Exp Med Biol 1977; 78:67-82.
14. Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol 2000; 7:53-58.
15. Albrich JM, McCarthy CA, Hurst JK. Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc Natl Acad Sci USA 1981; 78:210-214.
16. Borelli V, Banfi E, Perrotta MG, Zabucchi G. Myeloperoxidase exerts microbicidal activity against Mycobacterium tuberculosis. Infect Immun 1999; 67:4149-4152.
17. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67:1828-1836.
18. Nohl H, Jordan W, Hegner D. Identification of free hydroxyl radicals in respiring rat heart mitochondria by spin trapping with the nitrone DMPO. FEBS Lett 1981; 123:241-244.
19. Winterbourn CC. Hydroxyl radical production in body fluids. Roles of metal ions, ascorbate and superoxide. Biochem J 1981; 198:125-131.
20. Coonrod JD. Role of leukocytes in lung defenses. Respiration 1989; 55(suppl 1):9-13.
21. Shah M, Bry K, Hallman M. Protective effect of exogenous transferrin against hyperoxia: a study on premature rabbits. Pediatr Pulmonol 1997; 24:429-437.
22. Chao CC, Park SH, Aust AE. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch Biochem Biophys 1996; 326:152-157.
23. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-1624.
24. Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest 1994; 70:889-898.
25. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63: 152-157.
26. 2release by lung mitochondria and microsomes. Arch Biochem Biophys 1982; 217: 411-421.
27. Babior BM. Activation of the respiratory burst oxidase. Environ Health Perspect 1994; 102(suppl 10):53-56.
28. Adams LB, Dinauer MC, Morgenstern DE, Krahenbuhl JL. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber Lung Dis 1997; 78:237-246.
29. Cooper AM, Segal BH, Frank AA, Holland SM, Orme IM. Transient loss of resistance to pulmonary tuberculosis in p47(phox-=-) mice. Infect Immun 2000; 68:1231-1234.
30. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997; 185:207-218.
31. Weinbroum A, Nielsen VG, Tan S, Gelman S, Matalon S, Skinner KA, Bradley E Jr, Parks DA. Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. Am J Physiol 1995; 268:G988-G996.
32. Moncada S, Palmer RM, Higgs EA. Biosynthesis of nitric oxide from l-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 1989; 38:1709-1715.
33. Tayeh MA, Marletta MA. Oxidation of l-arginine to nitric oxide, nitrite, and nitrate: tetrahydrobiopterin is required as a cofactor. J Biol Chem 1989; 264:19654-19658.
34. Stuehr DJ, Kwon NS, Nathan CF. FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem Biophys Res Commun 1990; 168:558-565.
35. Kwon NS, Nathan CF, Gilker C, Griffith OW, Matthews D, Stuehr DJ. l-Citrulline production from l-arginine by macrophage nitric oxide synthase: the ureido oxygen derives from dioxygen. J Biol Chem 1990; 265: 13442-13445.
36. Garvey EP, Furfine ES, Sherman PA. Purification and inhibitor screening of human nitric oxide synthase isozymes. Methods Enzymol 1996; 268: 339-349.
37. Masters BSS, McMillan K, Sheta EA, Nishimura JS, Roman LJ, Martasek P. Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate-liganded heme protein that hydroxylates l-arginine to produce NO as a cellular signal. FASEB J 1996; 10:552-558.
38. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351:714-718.
39. Abu-Soud HM, Stuehr DJ. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA 1993; 90: 10769-10772.
40. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. Proc Natl Acad Sci USA 1996; 271:6518-6522.
41. Aymerich MS, Bengoechea-Alonso MT, Lopez-Zabalza MJ, Santiago E, Lopez-Moratalla N. Inducible nitric oxide synthase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. Biochem Biophys Res Commun 1998; 245:717-721.
42. Adcock IM, Brown CR, Kwon O, Barnes PJ. Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199:1518-1524.
43. Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997; 158:420-425.
44. Melillo G, Taylor LS, Brooks A, Musso T, Cox GW, Varesio L. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem 1997; 272:12236-12243.
45. Bellocq A, Suberville S, Philippe C, Bertrand F, Perez J, Fouqueray B, Cherqui G, Baud L. Low environmental pH is responsible for the induction of nitric oxide synthase in macrophages. J Biol Chem 1998; 273:5086-5092.
46. Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ. Autocrine= paracrine IFN-a=b mediates the lipopolysaccharide-induced activation of transcription factor Stat-1a in mouse macrophages: pivotal role of Stat-1a in induction of the inducible nitric oxide synthase gene. J Immunol 1998; 161:4803-4810.
47. Braun JS, Novak R, Gao G, Murray PJ, Shenep JL. Pneumolysin, a protein toxin of Streptococcus pneumoniael, induces nitric oxide production from macrophages. Infect Immun 1999; 67:3750-3756.
48. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Becherel P, Debre P, Moncada S, Mossalayi MD. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII=CD23 surface antigen. Proc Natl Acad Sci USA 1995; 92:7804-7808.
49. DeMaria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180:1999-2004.
50. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000; 12:64-76.
51. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323-350.
52. Hecker M, Cattaruzza M, Wagner AH. Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Gen Pharmacol 1999; 32:9-16.
53. Vodovotz Y, Russell D, Xie QW, Bogdan C, Nathan C. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J Immunol 1995; 154:2914-2925.
54. Tatoyan A, Giulivi C. Purification and characterization of a nitric oxide synthase from rat liver mitochondria. J Biol Chem 1998; 273:11044-11048.
55. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 1992; 176:599-604.
56. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol 1994; 152:4110-4118.
57. Hickman-Davis JM, Lindsey JR, Zhu S, Matalon S. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am J Physiol 1998; 274:L270-L277.
58. Xia Y, Roman LJ, Masters BS, Zweier JL. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem 1998; 273:22635-22639.
59. 2þ=calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998; 273:25804-25808.
60. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-650.
61. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100:2417-2423.
62. Shiloh MU, MacMicking JD, Nicholson S, Brause JE, Potter S, Marino M, Fang F, Dinauer M, Nathan C. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 1999; 10:29-38.
63. Hickman-Davis JM, O’Reilly P, Davis IC, Peti-Peterdi J, Davis G, Young KR, Devlin RB, Matalon S. Killing of Klebsiella pneumoniae by human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002; 282:L944-L956.
64. Fierro IM, Nascimento-DaSilva V, Arruda MA, Freitas MS, Plotkowski MC, Cunha FQ, Barja-Fidalgo C. Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J Leukoc Biol 1999; 65:508-514.
65. Kooy NW, Royall JA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys 1994; 310:352-359.
66. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993; 9: 371-377.
67. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91:10089-10093.
68. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995; 92: 7809-7813.
69. Pendino KJ, Laskin JD, Shuler RL, Punjabi CJ, Laskin DL. Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase. J Immunol 1993; 151:7196-7205.
70. Sittipunt C, Steinberg KP, Ruzinski JT, Myles C, Zhu S, Goodman RB, Hudson LD, Matalon S, Martin TR. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:503-510.
71. Tracey WR, Xue C, Klinghofer V, Barlow J, Pollock JS, Förstermann U, Johns RA. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol Lung Cell Mol Physiol 1994; 266:L722-L727.
72. Davis IC, Zajac AJ, Nolte KB, Botten J, Hjelle B, Matalon S. Elevated generation of reactive oxygen=nitrogen species in hantavirus cardiopulmonary syndrome. J Virol 2002; 76:8347-8359.
73. Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer 1998; 78:534-541.
74. Moodley YP, Chetty R, Lalloo UG. Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis. Eur Respir J 1999; 14:822-827.
75. Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155:1763-1769.
76. Nicholson S, Bonecini-Almeida MdG, Lapa eSJ, Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183:2293-2302.
77. Kobayashi A, Hashimoto S, Kooguchi K, Kitamura Y, Onodera H, Urata Y, Ashihara T. Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 1998; 113:1632-1639.
78. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
79. Doyle MP, Hoekstra JW. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem 1981; 14:351-358.
80. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405.
81. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271:C1424-C1437.
82. Heiss LN, Lancaster JR Jr, Corbett JA, Goldman WE. Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci USA 1994; 91:267-270.
83. Jia L, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380:221-226.
84. Mulligan MS, Hevel JM, Marletta MA, Ward PA. Tissue injury caused by deposition of immune complexes is l-arginine dependent. Proc Natl Acad Sci USA 1991; 88:6338-6342.
85. Berisha HI, Pakbaz H, Absood A, Said SI. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc Natl Acad Sci USA 1994; 91:7445-7449.
86. Ischiropoulos H, al-Mehdi AB, Fisher AB. Reactive species in ischemic rat lung injury: contribution of peroxynitrite. Am J Physiol 1995; 269: L158-L164.
87. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996; 93:2448-2453.
88. Kristof AS, Goldberg P, Laubach V, Hussain SN. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998; 158:1883-1889.
89. Karupiah G, Chen JH, Mahalingam S, Nathan CF, MacMicking JD. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med 1998; 188:1541-1546.
90. Szabo C, Billiar TR. Novel roles of nitric oxide in hemorrhagic shock. Shock 1999; 12:1-9.
91. Xiong Y, Karupiah G, Hogan SP, Foster PS, Ramsay AJ. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol 1999; 162:445-452.
92. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 1993; 18:195-199.
93. −: a pulse radiolysis study. Free Radic Biol Med 1995; 19:505-510.
94. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298:431-437.
95. Sampson JB, Rosen H, Beckman JS. Peroxynitrite-dependent tyrosine nitration catalyzed by superoxide dismutase, myeloperoxidase, and horseradish peroxidase. Methods Enzymol 1996; 269:210-218.
96. Tsai J-HM, Hamilton TP, Harrison JG, Jablowski M, van der Woerd M, Martin JC, Beckman JS. Role of peroxynitrite: conformation with its stability and toxicity. J Am Chem Soc 1994; 116:4115-4116.
97. Lancaster JR Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 1994; 91:8134-8141.
98. van der Vliet A, Smith D, O’Neill CA, Kaur H, Darley-Usmar V, Cross CE, Halliwell B. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 1994; 303: 295-301.
99. Carreras MC, Pargament GA, Catz SD, Poderoso JJ, Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett 1994; 341: 65-68.
100. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254:1001-1003.
101. Molina yVL, McDonald B, Reep B, Brune B, Di Silvio M, Billiar TR, Lapetina EG. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADPribosylation [published erratum appears in J Biol Chem 1993 Feb 5; 268(4):3016]. J Biol Chem 1992; 267:24929-24932.
102. Curran RD, Ferrari FK, Kispert PH, Stadler J, Stuehr DJ, Simmons RL, Billiar TR. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J 1991; 5:2085-2092.
103. Delaney CA, Green MH, Lowe JE, Green IC. Endogenous nitric oxide induced by interleukin-1 beta in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the ‘comet’ assay. FEBS Lett 1993; 333:291-295.
104. Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991; 174: 761-767.
105. Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994; 269:29405-29408.
106. Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 1994; 269:29409-29415.
107. Torres J, Davies N, Darley-Usmar VM, Wilson MT. The inhibition of cytochrome c oxidase by nitric oxide using S-nitrosoglutathione. J Inorg Biochem 1997; 66:207-212.
108. Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, Ischiropoulos H, Freeman BA, Radi R. Cytochrome c nitration by peroxynitrite. J Biol Chem 2000; 275:21409-21415.
109. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169:1543-1555.
110. Pilz RB, Suhasini M, Idriss S, Meinkoth JL, Boss GR. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J 1995; 9:552-558.
111. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96:60-68.
112. Colasanti M, Persichini T, Menegazzi M, Mariotto S, Giordano E, Caldarera CM, Sogos V, Lauro GM, Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem 1995; 270:26731-26733.
113. Lander HM, Sehajpal P, Levine DM, Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 1993; 150:1509-1516.
114. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994; 269:26066-26075.
115. Crow JP, Beckman JS, McCord JM. Sensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochemistry 1995; 34:3544-3552.
116. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364:626-632.
117. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993; 90:10957-10961.
118. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17:781-828.
119. Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, Miao QX, Kane LS, Gow AJ, Stamler JS. Fas-induced caspase denitrosylation. Science 1999; 284:651-654.
120. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1=Fas) signaling pathways. EMBO J 1998; 17:1675-1687.
121. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 1999; 274:22532-22538.
122. Denicola A, Freeman BA, Trujillo M, Radi R. Peroxynitrite reaction with carbon dioxide=bicarbonate: kinetics and influence on peroxynitrite-mediated oxidation. Arch Biochem Biophys 1996; 333:49-58.
123. Gow A, Duran D, Thom SR, Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys 1996; 333:42-48.
124. Lymar SV, Hurst JK. Carbon dioxide: physiological catalyst for peroxynitritemediated cellular damage or cellular protectant? Chem Res Toxicol 1996; 9:845-850
125. Lymar SV, Jiang Q, Hurst JK. Mechanism of carbon dioxide-catalyzed oxidation of tyrosine by peroxynitrite. Biochemistry 1996; 35:7855-7861.
126. Berlett BS, Levine RL, Stadtman ER. Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation. Proc Natl Acad Sci USA 1998; 95:2784-2789.
127. Pfeiffer S, Mayer B. Lack of tyrosine nitration by peroxynitrite generated at physiological pH. J Biol Chem 1998; 273:27280-27285.
128. Zhu S, Basiouny KF, Crow JP, Matalon S. Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2000; 278:L1025-L1031.
129. Evans TJ, Buttery LD, Carpenter A, Springall DR, Polak JM, Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 1996; 93:9553-9558.
130. van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 1997; 272:7617-7625.
131. Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 1996; 271:19199-19208.
132. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391:393-397.
133. Hazen SL, Zhang R, Shen Z, Wu W, Podrez EA, MacPherson JC, Schmitt D, Mitra SN, Mukhopadhyay C, Chen Y, et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 1999; 85: 950-958.
134. MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen SL. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001; 166:5763-5772.
135. Hickman-Davis JM, Lindsey JR, Matalon S. Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis. Infect Immun 2001; 69:6401-6410.
136. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, Heinecke JW. Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 2002; 109:1311-1319.
137. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, et al. A tale of two controversies: I Defining the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase deficient mice; and ii Defining the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002; 277:17415-17427.
138. Prutz WA, Monig H, Butler J, Land EJ. Reactions of nitrogen dioxide in aqueous model systems: oxidation of tyrosine units in peptides and proteins. Arch Biochem Biophys 1985; 243:125-134.
139. Beckman JS, Ischiropoulos H, Zhu L, van der WM, Smith C, Chen J, Harrison J, Martin JC, Tsai M. Kinetics of superoxide dismutase- and ironcatalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys 1992; 298:438-445.
140. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994; 375: 81-88.
141. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94:2407-2413.
142. Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF III, Finkel B, Lanken PN, Ischiropoulos H. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000; 278:L961-L967.
143. Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Goller NL, Ohnishi ST, Laskin DL. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukoc Biol 1994; 56:759-768.
144. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993; 265:L555-L564.
145. Haddad IY, Zhu S, Ischiropoulos H, Matalon S. Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am J Physiol 1996; 270:L281-L288.
146. McCall MN, Easterbrook-Smith SB. Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding of complement subcomponent C1q. Biochem J 1989; 257:845-851.
147. Vertessy BG, Zalud P, Nyman OP, Zeppezauer M. Identification of tyrosine as a functional residue in the active site of Escherichia coli dUTPase. Biochim Biophys Acta 1994; 1205:146-150.
148. 1-proteinase inhibitor upon chemical modification of its tyrosyl residues. J Biol Chem 1981; 256:6374-6380.
149. Kong SK, Yim MB, Stadtman ER, Chock PB. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. Proc Natl Acad Sci USA 1996; 93:3377-3382.
150. Greis KD, Zhu S, Matalon S. Identification of nitration sites on surfactant protein A by tandem electrospray mass spectrometry. Arch Biochem Biophys 1996; 335:396-402.
151. Zhu S, Haddad IY, Matalon S. Nitration of surfactant protein A (SP-A) tyrosine residues results in decreased mannose binding ability. Arch Biochem Biophys 1996; 333:282-290.
152. Zhu S, Kachel DL, Martin WJ, Matalon S. Nitrated SP-A does not enhance adherence of pneumocystis carinii to alveolar macrophages. Am J Physiol 1998; 275:L1031-L1039.
153. Robbins CG, Davis JM, Merritt TA, Amirkhanian JD, Sahgal N, Morin FC3, Horowitz S. Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am J Physiol 1995; 269: L545-L550.
154. Matalon S, DeMarco V, Haddad IY, Myles C, Skimming JW, Schurch S, Cheng S, Cassin S. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol 1996; 270:L273-L280.
155. Ignarro LJ. Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochem Soc Trans 1992; 20:465-469.
156. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 1993; 7:328-338.
157. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-4655.
158. Jain B, Rubinstein I, Robbins RA, Sisson JH. TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. Am J Physiol 1995; 268:L911-L917.
159. Adler KB, Fischer BM, Li H, Choe NH, Wright DT. Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 13:526-530.
160. Andonegui G, Trevani AS, Gamberale R, Carreras MC, Poderoso JJ, Giordano M, Geffner JR. Effect of nitric oxide donors on oxygen-dependent cytotoxic responses mediated by neutrophils. J Immunol 1999; 162: 2922-2930.
161. Wink DA, Hanbauer I, Laval F, Cook JA, Krishna MC, Mitchell JB. Nitric oxide protects against the cytotoxic effects of reactive oxygen species. Ann N Y Acad Sci 1994; 738:265-278.
162. Sharma VS, Traylor TG, Gardiner R, Mizukami H. Reaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry 1987; 26:3837-3843.
163. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991; 289:130-136.
164. White AC, Maloney EK, Boustani MR, Hassoun PM, Fanburg BL. Nitric oxide increases cellular glutathione levels in rat lung fibroblasts. Am J Respir Cell Mol Biol 1995; 13:442-448.
165. Eiserich JP, Butler J, van der Vliet A, Cross CE, Halliwell B. Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem J 1995; 310:745-749.
166. 2within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA 1998; 95:2175-2179.
167. Poss WB, Timmons OD, Farrukh IS, Hoidal JR, Michael JR. Inhaled nitric oxide prevents the increase in pulmonary vascular permeability caused by hydrogen peroxide. J Appl Physiol 1995; 79:886-891.
168. McElroy MC, Wiener-Kronish JP, Miyazaki H, Sawa T, Modelska K, Dobbs LG, Pittet JF. Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats. Am J Physiol 1997; 272:L631-L638.
169. Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L, Wigzell H. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 1999; 162:2829-2836.
170. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94:5243-5248.
171. Heath L, Chrisp C, Huffnagle G, LeGendre M, Osawa Y, Hurley M, Engleberg C, Fantone J, Brieland J. Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts. Infect Immun 1996; 64:5151-5160.
172. Cartner SC, Simecka JW, Briles DE, Cassell GH, Lindsey JR. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect Immun 1996; 64:5326-5331.
173. Davis JK, Parker RF, White H, Dziedzic D, Taylor G, Davidson MK, Cox NR, Cassell GH. Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL=6 and C3H=HeN mice. Infect Immun 1985; 50:647-654.
174. Parker RF, Davis JK, Blalock DK, Thorp RB, Simecka JW, Cassell GH. Pulmonary clearance of Mycoplasma pulmonis in C57BL=6N and C3H=HeN HeN mice:Infect Immun 1987; 55 : 2631-2635
175. Hickman-Davis J, Gibbs-Erwin J, Lindsey JR, Matalon S. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc Natl Acad Sci USA 1999; 96:4953-4958.
176. Kaplan SS, Lancaster JR Jr, Basford RE, Simmons RL. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun 1996; 64:69-76.
177. Assreuy J, Cunha FQ, Epperlein M, Noronha-Dutra A, O’Donnell CA, Liew FY, Moncada S. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol 1994; 24:672-676.
178. Fernandes PD, Assreuy J. Role of nitric oxide and superoxide in Giardia lamblia killing. Braz J Med Biol Res 1997; 30:93-99.
179. De Groote MA, Granger D, Xu Y, Campbell G, Prince R, Fang FC. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc Natl Acad Sci USA 1995; 92:6399-6403.
180. Brunelli L, Crow JP, Beckman JS. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch Biochem Biophys 1995; 316: 327-334.
181. Pacelli R, Wink DA, Cook JA, Krishna MC, DeGraff W, Friedman N, Tsokos M, Samuni A, Mitchell JB. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med 1995; 182:1469-1479.
182. Darrah PA, Hondalus MK, Chen Q, Ischiropoulos H, Mosser DM. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 2000; 68:3587-3593.
183. Fang FC. Perspectives series: host=pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99:2818-2825.
184. Ehrt S, Shiloh MU, Ruan J, Choi M, Gunzburg S, Nathan C, Xie Q, Riley LW. A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med 1997; 186:1885-1896.
185. Ruan J, St John G, Ehrt S, Riley L, Nathan C. noxR3 a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative oxidative stress. Infect Immun 1999; 67:3276-3283.
186. Glockzin S, von Knethen A, Scheffner M, Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem 1999; 274:19581-19586.
187. Williams MS, Noguchi S, Henkart PA, Osawa Y. Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 1998; 161: 6526-6531.
188. von Knethen A, Callsen D, Brune B. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol 1999; 163:2858-2866.
189. von Knethen A, Callsen D, Brune B. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell 1999; 10:361-372.
190. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349.
191. Matthay MA, Folkesson HG, Campagna A, Kheradmand F. Alveolar epithelial barrier and acute lung injury. New Horiz 1993; 1:613-622.
192. Barnard ML, Baker RR, Matalon S. Mitigation of oxidant injury to lung microvasculature by intratracheal instillation of antioxidant enzymes. Am J Physiol 1993; 265:L340-L345.
193. Robbins CG, Horowitz S, Merritt TA, Kheiter A, Tierney J, Narula P, Davis JM. Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia. Am J Physiol 1997; 272:L903-L907.
194. Flick MR, Hoeffel JM, Staub NC. Superoxide dismutase with heparin prevents increased lung vascular permeability during air emboli in sheep. J Appl Physiol 1983; 55:1284-1291.
195. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 1984; 73:1772-1784.
196. Gonzalez PK, Zhuang J, Doctrow SR, Malfroy B, Benson PF, Menconi MJ, Fink MP. EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther 1995; 275:798-806.
197. Al-Mehdi A, Shuman H, Fisher AB. Fluorescence microtopography of oxidative stress in lung ischemia-reperfusion. Lab Invest 1994; 70:579-587.
198. Matalon S, Haddad IY. Natural surfactant and hyperoxic lung injury in primates. J Appl Physiol 1994; 76:989-990.
199. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142:1250-1257.
200. Warner RL, Paine R3, Christensen PJ, Marletta MA, Richards MK, Wilcoxen SE, Ward PA. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 12:649-661.
201. Zhu S, Ware LB, Geiser T, Matthay MA, Matalon S. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001; 163: 166-172.
202. Lamb NJ, Quinlan GJ, Westerman ST, Gutteridge JM, Evans TW. Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide. Am J Respir Crit Care Med 1999; 160:1031-1034.
203. Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 1983; 71:754-761.
204. Sznajder JI, Fraiman A, Hall JB, SandersW, Schmidt G, Crawford G, Nahum A, Factor P, Wood LD. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96: 606-612.
205. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med 1997; 155:479-484.
206. de Andrade JA, Crow JP, Viera L, Bruce AC, Randall YK, McGiffin DC, Zorn GL, Zhu S, Matalon S, Jackson RM. Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts. Am J Respir Crit Care Med 2000; 161:2035-2042.
207. Tanaka S, Choe N, Hemenway DR, Zhu S, Matalon S, Kagan E. Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat. J Clin Invest 1998; 102:445-454.
208. Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 1999; 27:1738-1744.
209. Matalon S, DeMarco V, Haddad IY, Myles C, Skimming JW, Schurch S, Cheng S, Cassin S. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol 1996; 270:L273-L280.
210. Cross CE, Forte T, Stocker R, Louie S, Yamamoto Y, Ames BN, Frei B. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 1990; 115:396-404.
211. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25:180-185.
212. Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100:1397-1403.
213. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, Wright PE,. The Antioxidant in ARDS Study Group. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. Chest 1997; 112:164-172.
214. Molnar Z, Shearer E, Lowe D. N-acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective randomized placebo-controlled study. Crit Care Med 1999; 27:1100-1104.
215. Leff JA, Parsons PE, Day CE, Moore EE, Moore FA, Oppegard MA, Repine JE. Increased serum catalase activity in septic patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992; 146:985-989.
216. Leff JA, Parsons PE, Day CE, Taniguchi N, Jochum M, Fritz H, Moore FA, Moore EE, McCord JM, Repine JE. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993; 341:777-780.
217. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, Van Hoozen C, Wennberg AK, Nelson JL, Noursalehi M,. Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 1999; 27:1409-1420.